These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 24239568)

  • 1. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.
    Spite M; Clària J; Serhan CN
    Cell Metab; 2014 Jan; 19(1):21-36. PubMed ID: 24239568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
    Tang S; Wan M; Huang W; Stanton RC; Xu Y
    Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases.
    Abdolmaleki F; Kovanen PT; Mardani R; Gheibi-Hayat SM; Bo S; Sahebkar A
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):82-91. PubMed ID: 31267470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
    Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
    Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid mediators in the resolution of inflammation.
    Serhan CN; Chiang N; Dalli J; Levy BD
    Cold Spring Harb Perspect Biol; 2014 Oct; 7(2):a016311. PubMed ID: 25359497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of special proresolving mediators in pain relief.
    Zhang LY; Jia MR; Sun T
    Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of inflammation in oral diseases.
    Eltay EG; Van Dyke T
    Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytes from obese individuals exhibit an impaired SPM signature.
    López-Vicario C; Titos E; Walker ME; Alcaraz-Quiles J; Casulleras M; Durán-Güell M; Flores-Costa R; Pérez-Romero N; Forné M; Dalli J; Clària J
    FASEB J; 2019 Jun; 33(6):7072-7083. PubMed ID: 30840838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.
    Croasdell A; Thatcher TH; Kottmann RM; Colas RA; Dalli J; Serhan CN; Sime PJ; Phipps RP
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L888-901. PubMed ID: 26301452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
    Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines.
    Arnardottir HH; Dalli J; Colas RA; Shinohara M; Serhan CN
    J Immunol; 2014 Oct; 193(8):4235-44. PubMed ID: 25217168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.
    Serhan CN
    FASEB J; 2017 Apr; 31(4):1273-1288. PubMed ID: 28087575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.
    Perucci LO; Sugimoto MA; Gomes KB; Dusse LM; Teixeira MM; Sousa LP
    Expert Opin Ther Targets; 2017 Sep; 21(9):879-896. PubMed ID: 28786708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
    Fredman G; Serhan CN
    Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.
    Chiang N; Serhan CN
    Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma.
    Kytikova O; Novgorodtseva T; Denisenko Y; Antonyuk M; Gvozdenko T
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major structure-activity relationships of resolvins, protectins, maresins and their analogues.
    Daly K; O'Sullivan K; O'Sullivan TP
    Future Med Chem; 2022 Dec; 14(24):1943-1960. PubMed ID: 36449363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 Fatty acid supplementation and proresolving mediators of inflammation.
    Barden AE; Mas E; Mori TA
    Curr Opin Lipidol; 2016 Feb; 27(1):26-32. PubMed ID: 26655290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.